Rubicon Organics Inc. (OTCQX:ROMJF) Q2 2025 Earnings Conference Call August 18, 2025 10:00 AM ET
Company Participants
Margaret Ruth Brodie – CEO & Director
William Glenn Ibbott – Interim Chief Financial Officer
Conference Call Participants
Andrew Semple – Unidentified Company
Josh Felker – Unidentified Company
Neal Gilmer – Haywood Securities Inc., Research Division
Pablo Ernesto Zuanic – Zuanic & Associates
Operator
Good morning, ladies and gentlemen, and welcome to Rubicon Organics Second Quarter Earnings Call. [Operator Instructions] I would now like to turn the conference call over to Margaret Brodie. Please go ahead.
Margaret Ruth Brodie
Today, I’ll share an update on Rubicon Organics’ Q2 2025 performance, our growth opportunities and outlook. Glenn Ibbott will be walking you through our financial results. In Q2, we appointed Glenn Ibbott as Interim CFO, completed a $4.5 million private placement, finalized the acquisition of our Hope facility, launched our new all-in-one vape product to market, all while positioning the company for long-term success. We also delivered record results in the quarter.
Net revenue of $15 million, our highest ever single quarter, gross profit of $5.9 million, another record high and delivered adjusted EBITDA of $1.4 million, building on the $800,000 from Q1 ’25 for year-to-date $2.1 million. Rubicon’s growth continues to outpace total market. One of the key drivers behind our year-over-year growth was the exceptional performance of our 1964 510 thread Resin vape line launched in Q2 ’24 with just 2 SKUs, we expanded to 5 by year-end. And by the close of Q2 ’25, we have 7 SKUs in market, further strengthening our portfolio. These vape carts are extremely well received, quickly capturing over 15% of the segment and continuing to gain momentum.
Beyond resin vapes, we saw strong growth in 1964 pre-rolls, dried flower and concentrates along with gains in Simply Bare
#Rubicon #Organics #ROMJF #Earnings #Call #Transcript